Table 2 Effect of tranexamic acid (TXA) on death or hysterectomy
TXA | Placebo | Risk ratio (95 % CI) | p value* | |
|---|---|---|---|---|
(n = 10,000) | (n = 10,000) | |||
Death or hysterectomy | NN (X %) | NN (X %) | X.XX (X.XX–X.XX) | p = 0.XX |
Death (all causes) | NN (X %) | NN (X %) | X.XX (X.XX–X.XX) | p = 0.XX |
Bleeding deaths | NN (X %) | NN (X %) | X.XX (X.XX–X.XX) | p = 0.XX |
Disseminated intravascular coagulation deaths | NN (X %) | NN (X %) | X.XX (X.XX–X.XX) | p = 0.XX |
Pulmonary embolic deaths | NN (X %) | NN (X %) | X.XX (X.XX–X.XX) | p = 0.XX |
Sepsis deaths | NN (X %) | NN (X %) | X.XX (X.XX–X.XX) | p = 0.XX |
Deaths due to other causes | NN (X %) | NN (X %) | X.XX (X.XX–X.XX) | p = 0.XX |
Hysterectomy | NN (X %) | NN (X %) | X.XX (X.XX–X.XX) | p = 0.XX |